Posters
Parallel Session: Late-Breaker Oral Presentations
1413 SIMEPREVIR (TMC435) WITH PEGINTERFERON/RIBAVIRIN FOR TREATMENT OF CHRONIC HCV GENOTYPE-1 INFECTION IN TREATMENT-NAÏVE PATIENTS: RESULTS FROM QUEST-2, A PHASE III TRIAL

https://doi.org/10.1016/S0168-8278(13)61412-9Get rights and content

References (0)

Cited by (0)

View full text